LLMpediaThe first transparent, open encyclopedia generated by LLMs

Nature Methods

Generated by DeepSeek V3.2
Note: This article was automatically generated by a large language model (LLM) from purely parametric knowledge (no retrieval). It may contain inaccuracies or hallucinations. This encyclopedia is part of a research project currently under review.
Article Genealogy
Parent: Erica Xu Hop 4
Expansion Funnel Raw 54 → Dedup 16 → NER 3 → Enqueued 3
1. Extracted54
2. After dedup16 (None)
3. After NER3 (None)
Rejected: 13 (not NE: 13)
4. Enqueued3 (None)
Nature Methods
TitleNature Methods
DisciplineLife sciences, Biotechnology, Biochemistry
EditorDaniel Evanko
PublisherNature Portfolio
CountryUnited Kingdom
History2004–present
FrequencyMonthly
OpenaccessHybrid
Impact28.547 (2022)
ISSN1548-7091
EISSN1548-7105
Websitehttps://www.nature.com/nmeth/
CODENNMAEA3

Nature Methods. It is a monthly peer-reviewed scientific journal published by Nature Portfolio, focusing on the development and application of novel techniques across the life sciences. The journal emphasizes methodological innovation in areas such as biochemistry, cell biology, and genomics, providing researchers with detailed protocols and analyses. Its content is aimed at advancing experimental and computational approaches in biological and biomedical research.

Overview

The journal serves as a premier forum for presenting significant methodological advances that enable new biological discoveries. It covers a broad spectrum of techniques, from microscopy and spectroscopy to sequencing and data analysis. Articles often include rigorous validation and practical guidance for implementation in other laboratories. The publication is part of the prestigious Nature Research family, which includes titles like Nature Biotechnology and Nature Genetics. Its editorial standards are maintained by a team of professional editors with expertise in various sub-disciplines of the biological sciences.

History

The journal was launched in October 2004 by Nature Publishing Group, now known as Nature Portfolio, to address a growing need for a dedicated venue for methodological innovation. The founding editor was Daniel Evanko, who helped establish its focus on technically rigorous and broadly applicable new methods. Over the years, it has published seminal papers on technologies such as super-resolution microscopy, CRISPR gene editing, and single-cell RNA sequencing. Its establishment coincided with rapid technological progress in fields like proteomics and systems biology, filling a niche between traditional methods papers and primary research reports in journals like Science and Cell.

Impact and Reception

The journal quickly gained a high reputation within the scientific community, reflected in its consistently high impact factor and frequent citations in major research articles. It is regarded as essential reading for scientists developing new tools in neuroscience, cancer research, and developmental biology. Published methods have directly influenced projects like the Human Genome Project and the Brain Research through Advancing Innovative Neurotechnologies Initiative. The journal has received awards and acknowledgments from organizations such as the American Association for the Advancement of Science for its role in disseminating cutting-edge protocols.

Editorial Board and Publication

The editorial team is led by Daniel Evanko and includes professional editors with advanced degrees and research experience in fields like biophysics and molecular biology. The journal operates under the rigorous peer-review standards characteristic of the Nature Portfolio. Manuscripts are typically reviewed by experts from institutions like MIT, Stanford University, and the Max Planck Society. The publisher, Springer Nature, handles its production and distribution, offering both subscription and hybrid open access publishing options. The journal also organizes conferences and workshops, such as the Nature Methods: Techniques for Life Scientists symposium.

Content and Scope

Primary article types include Research Articles, Letters, Reviews, and Protocols, each detailing novel methods with comprehensive validation data. The journal places strong emphasis on techniques for imaging, genome editing, bioinformatics, and chemical biology. Regular features include "Technology of the Year" retrospectives and commentaries on emerging trends from leaders at places like the European Molecular Biology Laboratory and the Broad Institute. Its scope intentionally bridges disciplines, fostering collaboration between engineering, computer science, and biology, and it has been instrumental in standardizing methods for consortia like the International Human Epigenome Consortium.